Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diagnostic Imaging

  Free Subscription


Articles published in Eur J Neurol

Retrieve available abstracts of 194 articles:
HTML format



Single Articles


    April 2024
  1. EMMENEGGER TM, Pfyffer D, Curt A, Schading-Sassenhausen S, et al
    Longitudinal motor system changes from acute to chronic spinal cord injury.
    Eur J Neurol. 2024;31:e16196.
    PubMed     Abstract available


  2. DUKIC S, Fasano A, Coffey A, Buxo T, et al
    Electroencephalographic beta-band oscillations in the sensorimotor network reflect motor symptom severity in amyotrophic lateral sclerosis.
    Eur J Neurol. 2024;31:e16201.
    PubMed     Abstract available


  3. FERREIRA DE MATOS C, Cougoul P, Zaharie OM, Kermorgant M, et al
    Cerebrovascular and cardiovascular autonomic regulation in sickle cell patients with white matter lesions.
    Eur J Neurol. 2024;31:e16183.
    PubMed     Abstract available


    March 2024
  4. DE WEL B, Iterbeke L, Huysmans L, Peeters R, et al
    Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures.
    Eur J Neurol. 2024 Mar 20:e16282. doi: 10.1111/ene.16282.
    PubMed     Abstract available


  5. KHOSDELAZAD S, Spikman JM, Solvang S, Wermer MJH, et al
    Re-evaluating patient communication and care in angiographically negative subarachnoid hemorrhage: Balancing realism and optimism.
    Eur J Neurol. 2024 Mar 15:e16257. doi: 10.1111/ene.16257.
    PubMed     Abstract available


  6. SCHIEVINK WI
    Superficial siderosis and the dura.
    Eur J Neurol. 2024;31:e16182.
    PubMed    


    February 2024
  7. GAN Y, Su D, Zhang Z, Zhang Z, et al
    Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease.
    Eur J Neurol. 2024;31:e16147.
    PubMed     Abstract available


  8. DI NAPOLI J, Arighi A, Conte G, Carandini T, et al
    Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status.
    Eur J Neurol. 2024;31:e16124.
    PubMed     Abstract available


  9. FIRBANK MJ, Collerton D, Morgan KD, Schumacher J, et al
    Functional connectivity in Lewy body disease with visual hallucinations.
    Eur J Neurol. 2024;31:e16115.
    PubMed     Abstract available


  10. LEE H, Lee K, Kim YD, Nam HS, et al
    Association between substantia nigra degeneration and functional outcome in patients with basal ganglia infarction.
    Eur J Neurol. 2024;31:e16111.
    PubMed     Abstract available


  11. KINCL V, Panovsky R, Bockova M, Rektor I, et al
    Parkinson s disease cardiovascular symptoms: A new complex functional and structural insight.
    Eur J Neurol. 2024;31:e16110.
    PubMed     Abstract available


  12. MENETRE E, De Stefano P, Megevand P, Sarasin FP, et al
    Antiseizure medication
    Eur J Neurol. 2024;31:e16107.
    PubMed     Abstract available


  13. WU C, Wu H, Zhou C, Guan X, et al
    Cholinergic basal forebrain system degeneration underlies postural instability/gait difficulty and attention impairment in Parkinson's disease.
    Eur J Neurol. 2024;31:e16108.
    PubMed     Abstract available


    January 2024
  14. JACOBSEN LN, Stemmerik MG, Skriver SV, Pedersen JJ, et al
    Contractile properties and magnetic resonance imaging-assessed fat replacement of muscles in myotonia congenita.
    Eur J Neurol. 2024 Jan 25:e16207. doi: 10.1111/ene.16207.
    PubMed     Abstract available


  15. JENDE JME, Heutehaus L, Preisner F, Verez Sola CM, et al
    Magnetic resonance neurography in spinal cord injury: Imaging findings and clinical significance.
    Eur J Neurol. 2024 Jan 18:e16198. doi: 10.1111/ene.16198.
    PubMed     Abstract available


  16. ZHANG L, Li Y, Niu J, Hu N, et al
    Neuromuscular ultrasound in combination with nerve conduction studies helps identify inflammatory motor neuropathies from lower motor neuron syndromes.
    Eur J Neurol. 2024 Jan 18:e16202. doi: 10.1111/ene.16202.
    PubMed     Abstract available


  17. HOFFMANN O, Salih F, Masuhr F
    Computed tomography angiography in the diagnosis of brain death: Implementation and results in Germany.
    Eur J Neurol. 2024 Jan 12:e16209. doi: 10.1111/ene.16209.
    PubMed     Abstract available


  18. CALVI A, Mendelsohn Z, Hamed W, Chard D, et al
    Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis.
    Eur J Neurol. 2024;31:e16092.
    PubMed     Abstract available


  19. KIM ST, Kim SE, Lee DA, Lee HJ, et al
    Anti-seizure medication response and the glymphatic system in patients with focal epilepsy.
    Eur J Neurol. 2024;31:e16097.
    PubMed     Abstract available


    December 2023
  20. ALNASSER ALSUKHNI R, Vichayanrat E, Koay S, Davis LM, et al
    Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement.
    Eur J Neurol. 2023 Dec 12. doi: 10.1111/ene.16169.
    PubMed     Abstract available


  21. BLOK KM, Smolders J, van Rosmalen J, Martins Jarnalo CO, et al
    Real-world challenges in the diagnosis of primary progressive multiple sclerosis.
    Eur J Neurol. 2023;30:3799-3808.
    PubMed     Abstract available


  22. VIADER F
    Basal ganglia matter.
    Eur J Neurol. 2023;30:3638-3639.
    PubMed    


  23. FREUND BE, Sanchez-Boluarte SS, Blackmon K, Day GS, et al
    Incidence and risk factors associated with seizures in cerebral amyloid angiopathy.
    Eur J Neurol. 2023;30:3682-3691.
    PubMed     Abstract available


    November 2023
  24. SACCO R, Maino P, Koetsier E, Disanto G, et al
    Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients.
    Eur J Neurol. 2023 Nov 17. doi: 10.1111/ene.16146.
    PubMed     Abstract available


  25. KATZ M, Mork H, Baghdasaryan N, Hesse L, et al
    High-resolution nerve ultrasound and corneal confocal microscopy in taxane-induced polyneuropathy.
    Eur J Neurol. 2023 Nov 15. doi: 10.1111/ene.16141.
    PubMed     Abstract available


  26. WALTER U, Sobiella G, Prudlo J, Batchakaschvili M, et al
    Ultrasonic detection of vagus, accessory, and phrenic nerve atrophy in amyotrophic lateral sclerosis: Relation to impairment and mortality.
    Eur J Neurol. 2023 Nov 7. doi: 10.1111/ene.16127.
    PubMed     Abstract available


  27. FOESLEITNER O, Sturm V, Hayes J, Weiler M, et al
    Microstructural changes of peripheral nerves in early multiple sclerosis: A prospective magnetic resonance neurography study.
    Eur J Neurol. 2023 Nov 6. doi: 10.1111/ene.16126.
    PubMed     Abstract available


    October 2023
  28. ZHU C, Tian B
    Intracranial atherosclerotic plaques identified on vessel wall imaging are associated with increased risk of first-ever stroke in a large Chinese cohort.
    Eur J Neurol. 2023 Oct 12. doi: 10.1111/ene.16104.
    PubMed    


  29. JEONG SH, Jeong HJ, Sunwoo MK, Ahn SS, et al
    Association between choroid plexus volume and cognition in Parkinson disease.
    Eur J Neurol. 2023;30:3114-3123.
    PubMed     Abstract available


  30. STORTI B, Canavero I, Gabriel MM, Capozza A, et al
    Iatrogenic cerebral amyloid angiopathy: An illustrative case of a newly introduced disease.
    Eur J Neurol. 2023;30:3397-3399.
    PubMed     Abstract available


  31. HARDY TA
    Toward a serum biomarker of disease activity in Susac syndrome.
    Eur J Neurol. 2023;30:2953-2954.
    PubMed    


  32. CHEN S, Mitchell GA, Soucy JF, Gauthier J, et al
    TUFM variants lead to white matter abnormalities mimicking multiple sclerosis.
    Eur J Neurol. 2023;30:3400-3403.
    PubMed     Abstract available


  33. COELHO P, Madureira J, Franco A, Peralta AR, et al
    Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case-control study.
    Eur J Neurol. 2023;30:2999-3007.
    PubMed     Abstract available


    September 2023
  34. MIDAGLIA L, Rovira A, Miro B, Rio J, et al
    Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.
    Eur J Neurol. 2023 Sep 27. doi: 10.1111/ene.16077.
    PubMed     Abstract available


  35. LI S, Tang M, Zhang D, Han F, et al
    The prevalence and prognosis of asymptomatic intracranial atherosclerosis in a community-based population: Results based on high-resolution magnetic resonance imaging.
    Eur J Neurol. 2023 Sep 22. doi: 10.1111/ene.16057.
    PubMed     Abstract available


  36. DE COCK A, Van Ranst A, Costers L, Keytsman E, et al
    Reduced alpha2 power is associated with slowed information processing speed in multiple sclerosis.
    Eur J Neurol. 2023;30:2793-2800.
    PubMed     Abstract available


  37. WILLIAMS T, John N, Calvi A, Bianchi A, et al
    Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial.
    Eur J Neurol. 2023;30:2769-2780.
    PubMed     Abstract available


  38. WANG Y, Cai X, Li H, Jin A, et al
    Association of intracranial atherosclerosis with cerebral small vessel disease in a community-based population.
    Eur J Neurol. 2023;30:2700-2712.
    PubMed     Abstract available


  39. ESPARRAGOSA VAZQUEZ I, Ndiaye M, Di Stefano AL, Younan N, et al
    T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
    Eur J Neurol. 2023;30:2879-2883.
    PubMed     Abstract available


  40. THIMM A, Brakemeier S, Dag M, Munoz Rosales J, et al
    Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophy.
    Eur J Neurol. 2023;30:2821-2827.
    PubMed     Abstract available


    August 2023
  41. WEINSTEIN G, O'Donnell A, Frenzel S, Xiao T, et al
    Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross-Cohort Collaboration.
    Eur J Neurol. 2023 Aug 28. doi: 10.1111/ene.16048.
    PubMed     Abstract available


  42. SCHWORM B, Siedlecki J, Catarino C, von Livonius B, et al
    Age-dependent retinal neuroaxonal degeneration in children and adolescents with Leber hereditary optic neuropathy under idebenone therapy.
    Eur J Neurol. 2023;30:2525-2533.
    PubMed     Abstract available


  43. LEHTO J, Nylund M, Matilainen M, Sucksdorff M, et al
    Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis.
    Eur J Neurol. 2023;30:2365-2375.
    PubMed     Abstract available


    July 2023
  44. ARNALDI D, Mattioli P, Pardini M, Morbelli S, et al
    Clinical and dopaminergic imaging characteristics of the "FARPRESTO" cohort of trial-ready idiopathic REM sleep behavior patients.
    Eur J Neurol. 2023 Jul 27. doi: 10.1111/ene.16001.
    PubMed     Abstract available


  45. BSTEH G, Marik W, Macher S, Schmidbauer V, et al
    Impact of rater experience and referral question on detecting MRI features of idiopathic intracranial hypertension.
    Eur J Neurol. 2023 Jul 21. doi: 10.1111/ene.15986.
    PubMed     Abstract available


  46. ZHANG ZM, Si QQ, Chen HS, Yang Y, et al
    High-Resolution Magnetic Resonance Imaging of Acute Intracranial Artery Thrombus.
    Eur J Neurol. 2023 Jul 15. doi: 10.1111/ene.15985.
    PubMed     Abstract available


  47. HASSELBALCH SG, Carlsen JF, Alaouie MM, Munch TN, et al
    Prediction of shunt response in idiopathic normal pressure hydrocephalus by combined lumbar infusion test and preoperative imaging scoring.
    Eur J Neurol. 2023 Jul 11. doi: 10.1111/ene.15981.
    PubMed     Abstract available


  48. DURELLE C, Delmont E, Michel C, Trabelsi A, et al
    Quantification of muscle involvement by MRI in familial amyloid polyneuropathy.
    Eur J Neurol. 2023 Jul 9. doi: 10.1111/ene.15970.
    PubMed     Abstract available


  49. GERA O, Shavit-Stein E, Amichai T, Nikitin V, et al
    Exercise induced muscle blood flow is decreased in Charcot-Marie-Tooth disease type 1 polyneuropathy: a power Doppler analysis.
    Eur J Neurol. 2023;30:1991-2000.
    PubMed     Abstract available


    June 2023
  50. ABOU MRAD T, Naja K, Khoury SJ, Hannoun S, et al
    Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis.
    Eur J Neurol. 2023 Jun 23. doi: 10.1111/ene.15922.
    PubMed     Abstract available


  51. WIBAWA P, Walterfang M, Malpas CB, Glikmann-Johnston Y, et al
    Selective perforant-pathway atrophy in Huntington disease: MRI analysis of hippocampal subfields.
    Eur J Neurol. 2023 Jun 12. doi: 10.1111/ene.15918.
    PubMed     Abstract available


  52. PODAR IV, Gutmann DAP, Harmuth F, Haack TB, et al
    First case of adult-onset neuronal intranuclear inclusion disease with both typical radiological signs and NOTCH2NLC repeat expansions in a Caucasian individual.
    Eur J Neurol. 2023 Jun 4. doi: 10.1111/ene.15905.
    PubMed     Abstract available


  53. L W, K K, B VS, U H, et al
    Modulation of bodily response to chill stimuli by impaired structural connectivity of the left insula: a functional and lesion quantification study in stroke patients.
    Eur J Neurol. 2023;30:1706-1711.
    PubMed     Abstract available


  54. BRAUNER R, Gory B, Lapergue B, Sibon I, et al
    Effect of small vessel disease severity on blood pressure management after endovascular therapy in the BP TARGET trial.
    Eur J Neurol. 2023;30:1676-1685.
    PubMed     Abstract available


  55. NAWABI J, Orth T, Schulze-Weddige S, Baumgaertner GL, et al
    External validation of the diagnostic value of perihematomal edema characteristics in neoplastic and non-neoplastic intracerebral hemorrhage.
    Eur J Neurol. 2023;30:1686-1695.
    PubMed     Abstract available


  56. LI H, Zhang M, Wu Y, Li Y, et al
    Iron accumulation and axonal damage of cerebellum in idiopathic cervical dystonia.
    Eur J Neurol. 2023;30:1619-1630.
    PubMed     Abstract available


    May 2023
  57. MISTRI D, Cacciaguerra L, Valsasina P, Pagani E, et al
    Cognitive function in primary and secondary progressive multiple sclerosis: a multiparametric MRI study.
    Eur J Neurol. 2023 May 29. doi: 10.1111/ene.15900.
    PubMed     Abstract available


  58. SUN J, Xie Q, Gu J
    Comment on: Prognostic significance of the clinical and radiological haemorrhagic transformation subtypes in acute ischaemic stroke: A systematic review and meta-analysis.
    Eur J Neurol. 2023 May 18. doi: 10.1111/ene.15876.
    PubMed    


  59. COERVER EME, Janssens S, Ahmed A, Wessels MHJ, et al
    The association between age and inflammatory disease activity on MRI in relapse-onset multiple sclerosis during long-term follow-up.
    Eur J Neurol. 2023 May 12. doi: 10.1111/ene.15862.
    PubMed     Abstract available


  60. BERLING E, Verebi C, Venturelli N, Vassilopoulos S, et al
    Caveolinopathy: clinical, histological and muscle imaging features and follow-up in a multicenter retrospective cohort.
    Eur J Neurol. 2023 May 11. doi: 10.1111/ene.15832.
    PubMed     Abstract available


  61. MAUNULA A, Martola J, Atula S, Laakso SM, et al
    Incidental demyelination in magnetic resonance imaging and 10-year risk of multiple sclerosis: a data lake cohort study.
    Eur J Neurol. 2023 May 9. doi: 10.1111/ene.15849.
    PubMed     Abstract available


  62. JACOBI H, Weiler M, Sam G, Heiland S, et al
    Peripheral nerve involvement in hereditary spastic paraplegia characterized by quantitative magnetic resonance neurography.
    Eur J Neurol. 2023 May 8. doi: 10.1111/ene.15841.
    PubMed     Abstract available


  63. MASCALI D, Villani A, Chiarelli AM, Biondetti E, et al
    Pathophysiology of MS damage and repair: linking cerebral hypoperfusion to the development of irreversible tissue loss in MS using MRI.
    Eur J Neurol. 2023 May 8. doi: 10.1111/ene.15827.
    PubMed     Abstract available


  64. SANTOS AN, Rauschenbach L, Gull HH, Dinger TF, et al
    Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations.
    Eur J Neurol. 2023;30:1364-1370.
    PubMed     Abstract available


  65. RAUSCHER S, Santos AN, Gull HH, Rauschenbach L, et al
    Modifiable vascular risk factors in patients with cerebral and spinal cavernous malformations: a complete 10-year follow-up study.
    Eur J Neurol. 2023;30:1346-1351.
    PubMed     Abstract available


  66. GRONEWOLD J, Jokisch M, Schramm S, Himpfen H, et al
    Association of regional white matter hyperintensities with hypertension and cognition in the population-based 1000BRAINS study.
    Eur J Neurol. 2023;30:1174-1190.
    PubMed     Abstract available


  67. HOSOKI S, Fukuda-Doi M, Miwa K, Yoshimura S, et al
    Sequential detection rates of intramural hematoma for diagnosing spontaneous intracranial artery dissection.
    Eur J Neurol. 2023;30:1320-1326.
    PubMed     Abstract available


  68. ZICCARDI S, Pisani AI, Schiavi GM, Guandalini M, et al
    Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study.
    Eur J Neurol. 2023;30:1378-1388.
    PubMed     Abstract available


  69. TA D, Ishaque AH, Elamy A, Anand T, et al
    Severity of in vivo corticospinal tract degeneration is associated with survival in amyotrophic lateral sclerosis: a longitudinal, multicohort study.
    Eur J Neurol. 2023;30:1220-1231.
    PubMed     Abstract available


    April 2023
  70. DURRLEMAN C, Grevent D, Aubart M, Kossorotoff M, et al
    Clinical and radiological description of 120 pediatric stroke-like episodes.
    Eur J Neurol. 2023 Apr 12. doi: 10.1111/ene.15821.
    PubMed     Abstract available


  71. OPHEY A, Farrher E, Pagel N, Seger A, et al
    Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson's disease - a 7-T functional magnetic resonance spectroscopy study.
    Eur J Neurol. 2023 Apr 10. doi: 10.1111/ene.15818.
    PubMed     Abstract available


  72. BSTEH G, Hegen H, Altmann P, Auer M, et al
    Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis.
    Eur J Neurol. 2023;30:1025-1034.
    PubMed     Abstract available


  73. CARVALHO DE ABREU DC, Pieruccini-Faria F, Sarquis-Adamson Y, Black A, et al
    White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Eur J Neurol. 2023;30:920-933.
    PubMed     Abstract available


  74. WAUSCHKUHN J, Solorza Buenrostro G, Aly L, Asseyer S, et al
    Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.
    Eur J Neurol. 2023;30:982-990.
    PubMed     Abstract available


  75. CHEN Z, Chu M, Zhang J, Kong Y, et al
    Clinical profiles and ethnic heterogeneity of sporadic fatal insomnia.
    Eur J Neurol. 2023;30:813-822.
    PubMed     Abstract available


  76. LI G, Zhu J, Wu X, Liu T, et al
    Baseline free water within the visual processing system predicts future psychosis in Parkinson disease.
    Eur J Neurol. 2023;30:892-901.
    PubMed     Abstract available


  77. BRABENEC L, Simko P, Sejnoha Minsterova A, Kostalova M, et al
    Repetitive transcranial magnetic stimulation for hypokinetic dysarthria in Parkinson's disease enhances white matter integrity of the auditory-motor loop.
    Eur J Neurol. 2023;30:881-886.
    PubMed     Abstract available


    March 2023
  78. LIN BF, Hon F, Lin MY, Tsai PY, et al
    Right Arcuate Fasciculus as Outcome Predictor after Low-Frequency Repetitive Transcranial Magnetic Stimulation in Nonfluent Aphasic Stroke.
    Eur J Neurol. 2023 Mar 30. doi: 10.1111/ene.15808.
    PubMed     Abstract available


  79. RISSAN Z, Hansen NS, Carlsen LN, Korsbaek JJ, et al
    Fundus imaging and perimetry in patients with idiopathic intracranial hypertension - an intermethod and interrater validity study.
    Eur J Neurol. 2023 Mar 27. doi: 10.1111/ene.15802.
    PubMed     Abstract available


  80. ENAX-KRUMOVA E, Forsting J, Rohm M, Schwenkreis P, et al
    Letter to the Editor Reply to Finsterer and Mehri "Assessing post-COVID myopathy by MRI requires large cohorts and comparison with a gold standard".
    Eur J Neurol. 2023 Mar 14. doi: 10.1111/ene.15774.
    PubMed    


  81. HWANG J, Park HK, Yoon HJ, Jeong JH, et al
    Detecting amyloid-beta positivity using regions of interest from structural magnetic resonance imaging.
    Eur J Neurol. 2023 Mar 13. doi: 10.1111/ene.15775.
    PubMed     Abstract available


  82. FINSTERER J, Mehri S
    Assessing post-COVID myopathy by MRI requires large cohorts and comparison with a gold standard.
    Eur J Neurol. 2023 Mar 11. doi: 10.1111/ene.15780.
    PubMed    


  83. HERBER E, Aeschbacher S, Coslovsky M, Schwendinger F, et al
    Physical activity and brain health in patients with atrial fibrillation.
    Eur J Neurol. 2023;30:567-577.
    PubMed     Abstract available


  84. FORNO G, Contador J, Perez-Millan A, Guillen N, et al
    The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
    Eur J Neurol. 2023;30:597-605.
    PubMed     Abstract available


    February 2023
  85. SARDINA F, Valente D, Fattorini G, Cioffi E, et al
    New cellular imaging-based method to distinguish SPG4 subtype of Hereditary Spastic Paraplegia.
    Eur J Neurol. 2023 Feb 23. doi: 10.1111/ene.15756.
    PubMed     Abstract available


  86. TAHEDL M, Tan EL, Shing SLH, Chipika RH, et al
    Not a benign motor neuron disease: longitudinal imaging captures relentless motor connectome disintegration in Primary Lateral Sclerosis.
    Eur J Neurol. 2023 Feb 5. doi: 10.1111/ene.15725.
    PubMed     Abstract available


  87. DHANAPALARATNAM R, Issar T, Krishnan AV
    Hindsight for ultrasound imaging/measurement of the tibial nerve (answer).
    Eur J Neurol. 2023;30:564.
    PubMed    


  88. MATUSCHE B, Litvin L, Schneider R, Bellenberg B, et al
    Early spinal cord pseudoatrophy in interferon-beta-treated multiple sclerosis.
    Eur J Neurol. 2023;30:453-462.
    PubMed     Abstract available


  89. WANG L, Tan H, Yu J, ZhangBao J, et al
    Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: New insights from the FREEDOMS II study.
    Eur J Neurol. 2023;30:443-452.
    PubMed     Abstract available


    January 2023
  90. ENAX-KRUMOVA E, Forsting J, Rohm M, Schwenkreis P, et al
    Quantitative muscle MRI depicts microstructural abnormalities but no signs of inflammation or dystrophy in Post COVID-19 condition.
    Eur J Neurol. 2023 Jan 24. doi: 10.1111/ene.15709.
    PubMed     Abstract available


  91. HANI L, Fung C, Jesse CM, Schild C, et al
    Cerebrospinal fluid biomarkers of superficial siderosis in patients with spontaneous intracranial hypotension.
    Eur J Neurol. 2023;30:235-240.
    PubMed     Abstract available


  92. SANTOS AN, Rauschenbach L, Gull HH, Olbrich A, et al
    Central nervous system cavernous malformations: cross-sectional study assessing rebleeding risk after a second haemorrhage.
    Eur J Neurol. 2023;30:144-149.
    PubMed     Abstract available


  93. CORTESE R, Battaglini M, Sormani MP, Luchetti L, et al
    Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.
    Eur J Neurol. 2023;30:179-186.
    PubMed     Abstract available


    December 2022
  94. PSYCHOGIOS K, Georgios M, Safouris A, Kargiotis O, et al
    Bilateral dural arteriovenous fistula diagnosed with neurovascular ultrasonography.
    Eur J Neurol. 2022 Dec 5. doi: 10.1111/ene.15627.
    PubMed     Abstract available


  95. CONTADOR J, Perez-Millan A, Guillen N, Sarto J, et al
    Sex differences in early-onset Alzheimer's disease.
    Eur J Neurol. 2022;29:3623-3632.
    PubMed     Abstract available


    November 2022
  96. WOUTERS A, Scheldeman L, Liessens H, Dupont P, et al
    Sex differences in imaging and clinical characteristics of patients from the WAKE-UP trial.
    Eur J Neurol. 2022 Nov 9. doi: 10.1111/ene.15629.
    PubMed     Abstract available


  97. RICCI V, Guvener O, Ozcakar L
    Hindsight for Ultrasound Imaging/Measurement of the Tibial Nerve.
    Eur J Neurol. 2022 Nov 2. doi: 10.1111/ene.15622.
    PubMed    


  98. CHEN CH, Chu YT, Chen YF, Ko TY, et al
    Comparison of clinical and neuroimaging features between NOTCH3 mutations and nongenetic spontaneous intracerebral haemorrhage.
    Eur J Neurol. 2022;29:3243-3254.
    PubMed     Abstract available


  99. POURZINAL D, Yang J, Lawson RA, McMahon KL, et al
    Systematic review of data-driven cognitive subtypes in Parkinson disease.
    Eur J Neurol. 2022;29:3395-3417.
    PubMed     Abstract available


    October 2022
  100. BUCIUC M, Koga S, Pham NTT, Duffy JR, et al
    The many faces of globular glial tauopathy: a clinical and imaging study.
    Eur J Neurol. 2022 Oct 18. doi: 10.1111/ene.15603.
    PubMed     Abstract available


  101. SONKSEN SE, Kuhn S, Basner M, Gerlach D, et al
    Brain structure and neurocognitive function in two professional mountaineers during 35 days of severe normobaric hypoxia.
    Eur J Neurol. 2022;29:3112-3116.
    PubMed     Abstract available


  102. STASCHEIT F, Rubsam A, Otto C, Meisel A, et al
    Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case series.
    Eur J Neurol. 2022;29:3028-3038.
    PubMed     Abstract available


  103. DOMPMARTIN A, van der Vleuten CJM, Dekeuleneer V, Duprez T, et al
    GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features.
    Eur J Neurol. 2022;29:3061-3070.
    PubMed     Abstract available


  104. XU J, Su Y, Fu J, Wang X, et al
    Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
    Eur J Neurol. 2022;29:2895-2904.
    PubMed     Abstract available


  105. BENKE T, Bodner T, Wiesen D, Karnath HO, et al
    The amnestic syndrome of posterior cerebral artery infarction.
    Eur J Neurol. 2022;29:2987-2995.
    PubMed     Abstract available


  106. RUIZ-RIZZO AL, Bublak P, Kluckow S, Finke K, et al
    Neural distinctiveness of fatigue and low sleep quality in multiple sclerosis.
    Eur J Neurol. 2022;29:3017-3027.
    PubMed     Abstract available


    September 2022
  107. GALGANI A, Lombardo F, Martini N, Vergallo A, et al
    MRI Locus Coeruleus abnormality in amnestic mild cognitive impairment is associated with future progression to dementia.
    Eur J Neurol. 2022 Sep 10. doi: 10.1111/ene.15556.
    PubMed     Abstract available


  108. DESCHAMPS R, Shor N, Vignal C, Guillaume J, et al
    Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis.
    Eur J Neurol. 2022;29:2781-2791.
    PubMed     Abstract available


  109. LI J, Chen Y, Ou Z, Zhang Y, et al
    Glucose-6-phosphate dehydrogenase deficiency and intracranial atherosclerotic stenosis in stroke patients.
    Eur J Neurol. 2022;29:2683-2689.
    PubMed     Abstract available


    August 2022
  110. DHANAPALARATNAM R, Issar T, Poynten AM, Milner KL, et al
    Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes.
    Eur J Neurol. 2022 Aug 30. doi: 10.1111/ene.15534.
    PubMed     Abstract available


  111. ISELLA V, Licciardo D, Nastasi G, Impagnatiello V, et al
    Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy.
    Eur J Neurol. 2022 Aug 11. doi: 10.1111/ene.15520.
    PubMed     Abstract available


  112. CIOLAC D, Gonzalez-Escamilla G, Winter Y, Melzer N, et al
    Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis.
    Eur J Neurol. 2022;29:2309-2320.
    PubMed     Abstract available


  113. ZHOU X, Li T, Qu W, Pan D, et al
    Abnormalities of retinal structure and microvasculature are associated with cerebral white matter hyperintensities.
    Eur J Neurol. 2022;29:2289-2298.
    PubMed     Abstract available


  114. JAKIMOVSKI D, Gibney BL, Marr K, Ramasamy DP, et al
    Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients.
    Eur J Neurol. 2022;29:2299-2308.
    PubMed     Abstract available


  115. MA X, Guo Z, Huang Z, Hui D, et al
    Enhancement pattern of demyelination-mimicking cerebral B-cell lymphoma.
    Eur J Neurol. 2022;29:2499-2504.
    PubMed     Abstract available


  116. CHENG Z, Zhang W, Zhan Z, Xia L, et al
    Cerebral small vessel disease and prognosis in intracerebral haemorrhage: A systematic review and meta-analysis of cohort studies.
    Eur J Neurol. 2022;29:2511-2525.
    PubMed     Abstract available


    July 2022
  117. CICERO CE, Donzuso G, Luca A, Davi M, et al
    Morphometric MRI Cortico-subcortical features in Parkinson's Disease with mild cognitive impairment.
    Eur J Neurol. 2022 Jul 5. doi: 10.1111/ene.15489.
    PubMed     Abstract available


  118. HE J, Fu F, Zhang W, Zhan Z, et al
    Prognostic Significance of the Clinical and Radiological Haemorrhage Transformation Subtypes in Acute Ischaemic Stroke: A Systematic Review and Meta-analysis.
    Eur J Neurol. 2022 Jul 5. doi: 10.1111/ene.15482.
    PubMed     Abstract available


  119. MACIVER CL, Tax CMW, Jones D, Peall KJ, et al
    Structural Magnetic Resonance Imaging in Dystonia: a systematic review of methodological approaches and findings.
    Eur J Neurol. 2022 Jul 4. doi: 10.1111/ene.15483.
    PubMed     Abstract available


  120. TOMMASIN S, Iakovleva V, Rocca MA, Gianni C, et al
    Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability.
    Eur J Neurol. 2022;29:2036-2046.
    PubMed     Abstract available


  121. BATTAGLINI M, Vrenken H, Tappa Brocci R, Gentile G, et al
    Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a.
    Eur J Neurol. 2022;29:2024-2035.
    PubMed     Abstract available


  122. KALEN E, Piehl F, Andersson M
    Demyelinating events following anti-tumor necrosis factor alpha therapy: Rare but challenging to treat.
    Eur J Neurol. 2022;29:2047-2055.
    PubMed     Abstract available


    June 2022
  123. MAZZUCCHI S, Del Prete E, Costagli M, Frosini D, et al
    Morphometric Imaging and Quantitative Susceptibility Mapping as complementary tools in the diagnosis of parkinsonisms.
    Eur J Neurol. 2022 Jun 14. doi: 10.1111/ene.15447.
    PubMed     Abstract available


  124. TRIPLETT JD, Qiu J, O'Brien B, Gopinath S, et al
    Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome.
    Eur J Neurol. 2022;29:1771-1781.
    PubMed     Abstract available


  125. NOLTE JYC, Ten Dam L, van de Beek D, Brouwer MC, et al
    Clinical characteristics and outcome of neurosarcoidosis-associated myelitis: A retrospective cohort study and review of the literature.
    Eur J Neurol. 2022;29:1763-1770.
    PubMed     Abstract available


  126. TESTUD B, Delacour C, El Ahmadi AA, Brun G, et al
    Brain grey matter perfusion in primary progressive multiple sclerosis: Mild decrease over years and regional associations with cognition and hand function.
    Eur J Neurol. 2022;29:1741-1752.
    PubMed     Abstract available


  127. RICIGLIANO VAG, Tonietto M, Hamzaoui M, Poirion E, et al
    Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis.
    Eur J Neurol. 2022;29:1719-1729.
    PubMed     Abstract available


  128. YAQUB A, K L Darweesh S, J Dommershuijsen L, W Vernooij M, et al
    Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population-based comparison with mild cognitive impairment.
    Eur J Neurol. 2022;29:1587-1599.
    PubMed     Abstract available


  129. LIU P, Yang D, Zhang F, Chen S, et al
    The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study.
    Eur J Neurol. 2022;29:1610-1618.
    PubMed     Abstract available


  130. ZOLLNER JP, Wichert J, Schubert-Bast S, Hattingen E, et al
    Local glucose metabolism is unaltered in reversible splenial lesion syndrome.
    Eur J Neurol. 2022;29:1836-1840.
    PubMed     Abstract available


    May 2022
  131. ADAMS A, Tilden W, Bestwick J, Holden D, et al
    The relationship of CSF neurofilament levels with MRI lesion location and disease activity in Multiple Sclerosis.
    Eur J Neurol. 2022 May 26. doi: 10.1111/ene.15419.
    PubMed     Abstract available


  132. SHANG ZY, Tao L, Li XQ, Yang BQ, et al
    The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: an analysis of different subtypes based on high-resolution imaging.
    Eur J Neurol. 2022 May 20. doi: 10.1111/ene.15409.
    PubMed     Abstract available


  133. ZHANG J, Sun D, Tian F
    Letter to the Editor: "Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study".
    Eur J Neurol. 2022;29:e13-e14.
    PubMed    


  134. TEIPEL SJ, Grothe MJ
    Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
    Eur J Neurol. 2022;29:1394-1401.
    PubMed     Abstract available


  135. WENDEBOURG MJ, Weigel M, Richter L, Gocheva V, et al
    Spinal cord gray matter atrophy is associated with functional decline in post-polio syndrome.
    Eur J Neurol. 2022;29:1435-1445.
    PubMed     Abstract available


  136. FRIEDRICH MU, Eldebakey H, Roothans J, Capetian P, et al
    Current-dependent ocular tilt reaction in deep brain stimulation of the subthalamic nucleus: Evidence for an incerto-interstitial pathway?
    Eur J Neurol. 2022;29:1545-1549.
    PubMed     Abstract available


  137. SANTOS AN, Rauschenbach L, Saban D, Chen B, et al
    Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.
    Eur J Neurol. 2022;29:1427-1434.
    PubMed     Abstract available


  138. ISMAIL FS, Spatola M, Woermann FG, Popkirov S, et al
    Diagnostic challenges in patients with temporal lobe seizures and features of autoimmune limbic encephalitis.
    Eur J Neurol. 2022;29:1303-1310.
    PubMed     Abstract available


    April 2022
  139. LUO Y, Guo Y, Zhong L, Liu Y, et al
    Abnormal dynamic brain activity and functional connectivity of primary motor cortex in blepharospasm.
    Eur J Neurol. 2022;29:1035-1043.
    PubMed     Abstract available


  140. TRANDAFIR C, Laurent-Chabalier S, Cosma C, Frandon J, et al
    Association of symptomatic atherosclerotic carotid arteries with plaque areas showing low densities on computed tomographic angiography.
    Eur J Neurol. 2022;29:1056-1061.
    PubMed     Abstract available


  141. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosis.
    Eur J Neurol. 2022;29:1106-1116.
    PubMed     Abstract available


  142. LABEIT B, Grond T, Beule AG, Boehmer M, et al
    Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm.
    Eur J Neurol. 2022;29:1165-1173.
    PubMed     Abstract available


  143. FRIEDAUER L, Rezny-Kasprzak B, Steinmetz H, du Mesnil de Rochemont R, et al
    Spinal dural leaks in patients with infratentorial superficial siderosis of the central nervous system-Refinement of a diagnostic algorithm.
    Eur J Neurol. 2022;29:1136-1144.
    PubMed     Abstract available


    March 2022
  144. MOSTEIRO A, Compta Y, Valldeoriola F, Rumia J, et al
    Deep brain stimulation as a palliative treatment for myorhythmia: A case of failure.
    Eur J Neurol. 2022;29:937-941.
    PubMed     Abstract available


  145. TONELLO S, Grossi U, Trincia E, Zanus G, et al
    First-line steroid treatment for spontaneous intracranial hypotension.
    Eur J Neurol. 2022;29:947-949.
    PubMed     Abstract available


  146. DING L, Liu Z, Mane R, Wang S, et al
    Predicting functional outcome in patients with acute brainstem infarction using deep neuroimaging features.
    Eur J Neurol. 2022;29:744-752.
    PubMed     Abstract available


  147. PARASKEVAS GP, Stefanou MI, Constantinides VC, Bakola E, et al
    CADASIL in Greece: Mutational spectrum and clinical characteristics based on a systematic review and pooled analysis of published cases.
    Eur J Neurol. 2022;29:810-819.
    PubMed     Abstract available


  148. VERMERSCH P, Oreja-Guevara C, Siva A, Van Wijmeersch B, et al
    Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial.
    Eur J Neurol. 2022;29:790-801.
    PubMed     Abstract available


  149. SIHVONEN AJ, Sammler D, Ripolles P, Leo V, et al
    Right ventral stream damage underlies both poststroke aprosodia and amusia.
    Eur J Neurol. 2022;29:873-882.
    PubMed     Abstract available


    February 2022
  150. KOLLMER J, Weiler M, Sam G, Faber J, et al
    Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre-ataxic spinocerebellar ataxia type 3.
    Eur J Neurol. 2022 Feb 28. doi: 10.1111/ene.15305.
    PubMed     Abstract available


  151. DE PAIVA ARB, Fonseca Neto RE, Afonso C, Freua F, et al
    Incidental MRI findings leading to an unusual diagnosis: adult-onset Krabbe disease.
    Eur J Neurol. 2022 Feb 24. doi: 10.1111/ene.15298.
    PubMed     Abstract available


  152. MENG D, Mohammadi-Nejad AR, Sotiropoulos SN, Auer DP, et al
    Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment.
    Eur J Neurol. 2022 Feb 7. doi: 10.1111/ene.15251.
    PubMed     Abstract available


  153. SCHAEFFER E, Roeben B, Granert O, Hanert A, et al
    Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's disease.
    Eur J Neurol. 2022;29:441-449.
    PubMed     Abstract available


  154. KANG SH, Woo SY, Kim S, Kim JP, et al
    Independent effects of amyloid and vascular markers on long-term functional outcomes: An 8-year longitudinal study of subcortical vascular cognitive impairment.
    Eur J Neurol. 2022;29:413-421.
    PubMed     Abstract available


  155. PETRACCA M, Cutter G, Cocozza S, Freeman L, et al
    Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial.
    Eur J Neurol. 2022;29:515-521.
    PubMed     Abstract available


  156. ARGENTO O, Spano B, Serra L, Incerti CC, et al
    Relapsing-remitting and secondary-progressive multiple sclerosis patients differ in decoding others' emotions by their eyes.
    Eur J Neurol. 2022;29:505-514.
    PubMed     Abstract available


  157. OOSTERBOS C, Decramer T, Rummens S, Weyns F, et al
    Evidence in peroneal nerve entrapment: A scoping review.
    Eur J Neurol. 2022;29:665-679.
    PubMed     Abstract available


  158. OGURA A, Kawabata K, Watanabe H, Choy SW, et al
    Fiber-specific white matter analysis reflects upper motor neuron impairment in amyotrophic lateral sclerosis.
    Eur J Neurol. 2022;29:432-440.
    PubMed     Abstract available


    January 2022
  159. UHER T, Kubala Havrdova E, Vodehnalova K, Krasensky J, et al
    Pregnancy-induced brain MRI changes in women with multiple sclerosis.
    Eur J Neurol. 2022 Jan 11. doi: 10.1111/ene.15245.
    PubMed     Abstract available


  160. KALTENIECE A, Ferdousi M, Azmi S, Khan SU, et al
    Corneal nerve loss is related to the severity of painful diabetic neuropathy.
    Eur J Neurol. 2022;29:286-294.
    PubMed     Abstract available


  161. WU P, Pang X, Liang X, Wei W, et al
    Correlation analysis between regional homogeneity and executive dysfunction in anti-N-methyl-D-aspartate receptor encephalitis patients.
    Eur J Neurol. 2022;29:277-285.
    PubMed     Abstract available


  162. AYRIGNAC X, Carra-Dalliere C, Codjia P, Mouzat K, et al
    Evaluation of CSF1R-related adult onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria.
    Eur J Neurol. 2022;29:329-334.
    PubMed     Abstract available


  163. JOKINEN H, Laakso HM, Ahlstrom M, Arola A, et al
    Synergistic associations of cognitive and motor impairments with functional outcome in covert cerebral small vessel disease.
    Eur J Neurol. 2022;29:158-167.
    PubMed     Abstract available


  164. SILVESTRO M, Tessitore A, Di Nardo F, Scotto di Clemente F, et al
    Functional connectivity changes in complex migraine aura: beyond the visual network.
    Eur J Neurol. 2022;29:295-304.
    PubMed     Abstract available


    December 2021
  165. GU L, Guan X, Gao T, Zhou C, et al
    The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging study.
    Eur J Neurol. 2021 Dec 9. doi: 10.1111/ene.15201.
    PubMed     Abstract available


  166. MARTINS AI, Figueiredo C, Melancia D, Jorge A, et al
    Labyrinthine haemorrhage secondary to cerebral venous thrombosis.
    Eur J Neurol. 2021;28:4258-4260.
    PubMed     Abstract available


  167. POLLET M, Skrobala E, Lopes R, Kuchcinski G, et al
    A multimodal, longitudinal study of cognitive heterogeneity in early-onset Alzheimer's disease.
    Eur J Neurol. 2021;28:3990-3998.
    PubMed     Abstract available


  168. TSAGKAS C, Naegelin Y, Amann M, Papadopoulou A, et al
    Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
    Eur J Neurol. 2021;28:4153-4166.
    PubMed     Abstract available


  169. YOO HS, Kwon H, Chung SJ, Sohn YH, et al
    Neural correlates of self-awareness of cognitive deficits in non-demented patients with Parkinson's disease.
    Eur J Neurol. 2021;28:4022-4030.
    PubMed     Abstract available


  170. LANGDON DW, Tomic D, Penner IK, Calabrese P, et al
    Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.
    Eur J Neurol. 2021;28:4135-4145.
    PubMed     Abstract available


  171. SWART G, Blair C, Lu Z, Yogendran S, et al
    Nitrous oxide-induced myeloneuropathy.
    Eur J Neurol. 2021;28:3938-3944.
    PubMed     Abstract available


  172. CACCIAGUERRA L, Valsasina P, Meani A, Riccitelli GC, et al
    Volume of hippocampal subfields and cognitive deficits in neuromyelitis optica spectrum disorders.
    Eur J Neurol. 2021;28:4167-4177.
    PubMed     Abstract available


  173. WICKLEIN R, Wauschkuhn J, Giglhuber K, Kumpfel T, et al
    Association of peripapillary hyper-reflective ovoid masslike structures and disease duration in primary progressive multiple sclerosis.
    Eur J Neurol. 2021;28.
    PubMed     Abstract available


    November 2021
  174. CLIFFORD DB
    The devil's details: Pathologic correlates of PML MRI imaging.
    Eur J Neurol. 2021 Nov 19. doi: 10.1111/ene.15188.
    PubMed     Abstract available


  175. CARNERO CONTENTTI E, Lopez PA, Criniti J, Pettinicchi JP, et al
    Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
    Eur J Neurol. 2021 Nov 19. doi: 10.1111/ene.15178.
    PubMed     Abstract available


  176. FEREIDAN-ESFAHANI M, Decker PA, Eckel Passow JE, Lucchinetti CF, et al
    Population-based Incidence and Clinico-radiological Characteristics of Tumefactive Demyelination in Olmsted County, Minnesota, USA.
    Eur J Neurol. 2021 Nov 12. doi: 10.1111/ene.15182.
    PubMed     Abstract available


  177. GARIBALDI M, Nicoletti T, Bucci E, Fionda L, et al
    Muscle MRI in Myotonic Dystrophy type 1 (DM1): refining muscle involvement and implications for clinical trials.
    Eur J Neurol. 2021 Nov 9. doi: 10.1111/ene.15174.
    PubMed     Abstract available


  178. ZIEMELE D, Kauke G, Skrejane K, Jaunozolina L, et al
    A fatal case of COVID-19-associated acute necrotizing encephalopathy.
    Eur J Neurol. 2021;28:3870-3872.
    PubMed     Abstract available


  179. PSYCHOGIOS K, Xiromerisiou G, Kargiotis O, Safouris A, et al
    Hereditary cerebral amyloid angiopathy mimicking CADASIL syndrome.
    Eur J Neurol. 2021;28:3866-3869.
    PubMed     Abstract available


  180. ZHU C, Mossa-Basha M
    Wall enhancement as an emerging marker of intracranial aneurysm stability: Roadmap toward a potential target for clinical trials.
    Eur J Neurol. 2021;28:3550-3551.
    PubMed    


  181. MOLENBERG R, Aalbers MW, Appelman APA, Uyttenboogaart M, et al
    Intracranial aneurysm wall enhancement as an indicator of instability: a systematic review and meta-analysis.
    Eur J Neurol. 2021;28:3837-3848.
    PubMed     Abstract available


  182. KUHNLEIN P, Mahnkopf C, Majersik JJ, Wilson BD, et al
    Atrial fibrosis in embolic stroke of undetermined source: A multicenter study.
    Eur J Neurol. 2021;28:3634-3639.
    PubMed     Abstract available


  183. LAMBERT N, El Moussaoui M, Maquet P
    Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors.
    Eur J Neurol. 2021;28:3814-3819.
    PubMed     Abstract available


  184. ARGIRO A, Sciagra R, Marchi A, Beltrami M, et al
    Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Eur J Neurol. 2021;28:3809-3813.
    PubMed     Abstract available


    October 2021
  185. ZEINER PS, Mann L, Filipski K, Starzetz T, et al
    Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy.
    Eur J Neurol. 2021 Oct 13. doi: 10.1111/ene.15140.
    PubMed     Abstract available


    September 2021
  186. MAZZACANE F, Zito A, Magno S, Persico A, et al
    Vessel Wall Magnetic Resonance Imaging in Covid-19 associated Cryptogenic Ischemic Stroke.
    Eur J Neurol. 2021 Sep 27. doi: 10.1111/ene.15128.
    PubMed     Abstract available


  187. ROTHER C, Bumb JM, Weiler M, Brault A, et al
    Characterization and quantification of alcohol-related polyneuropathy by magnetic resonance neurography.
    Eur J Neurol. 2021 Sep 26. doi: 10.1111/ene.15127.
    PubMed     Abstract available


  188. ISHIKAWA H, Mandel-Brehm C, Shindo A, Cady MA, et al
    Long-term MRI changes in a patient with Kelch-like protein 11-associated paraneoplastic neurological syndrome.
    Eur J Neurol. 2021 Sep 24. doi: 10.1111/ene.15120.
    PubMed     Abstract available


  189. SU Y, Fu J, Zhang Y, Xu J, et al
    Visuospatial dysfunction is associated with posterior distribution of white matter damage in non-demented cerebral amyloid angiopathy.
    Eur J Neurol. 2021;28:3113-3120.
    PubMed     Abstract available


  190. KOBELEVA X, Machts J, Veit M, Vielhaber S, et al
    Brain activity is contingent on neuropsychological function in a functional magnetic resonance imaging study of verbal working memory in amyotrophic lateral sclerosis.
    Eur J Neurol. 2021;28:3051-3060.
    PubMed     Abstract available


  191. SCHUMANN-WERNER B, Dogan I, Mirzazade S, Mall B, et al
    Clinical predictors and neural correlates for compromised swallowing safety in Huntington disease.
    Eur J Neurol. 2021;28:2855-2862.
    PubMed     Abstract available


  192. KORTAZAR-ZUBIZARRETA I, Ruiz-Onandi R, Pereda A, Vado Y, et al
    Sporadic Creutzfeldt-Jakob disease with extremely long 14-year survival period.
    Eur J Neurol. 2021;28:2901-2906.
    PubMed     Abstract available


  193. VILLA E, Sarquis T, de Grazia J, Nunez R, et al
    Rheumatoid meningitis: A systematic review and meta-analysis.
    Eur J Neurol. 2021;28:3201-3210.
    PubMed     Abstract available


  194. KELLER J, Kavkova A, Matej R, Csefalvay Z, et al
    Corpus callosum hypersignals and focal atrophy: neuroimaging findings in globular glial tauopathy type I.
    Eur J Neurol. 2021 Sep 1. doi: 10.1111/ene.15090.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diagnostic Imaging is free of charge.